SHRADDHA KHOKHAL: Open Payments
NPI 1215707096 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 32 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $363 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $229 |
| Lilly USA, LLC | 4 | $176 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
| Novo Nordisk Inc | 3 | $47 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: VRAYLAR, ZEPBOUND, MOUNJARO, Belbuca, QULIPTA, Wegovy, AIRSUPRA, Zoryve.
Industry payments across NC — which companies pay providers there.
